Interestingly, MECR had context-specific effects on CD4+ T cell subsets, with Th1 cells having no effect in acute in vitro assays, whereas IFNγ and T-bet were decreased with Mecr-KO in chronic in vivo IBD models. The gene discussed is CD4; the disease is inflammatory bowel disease.